Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


03.12.2018

1 Br J Cancer
1 Cancer
1 Cancer Res
3 Clin Cancer Res
1 Int J Radiat Oncol Biol Phys
16 J Neurooncol
10 J Neurosurg
4 Neuro Oncol
1 Neurology
10 Neurosurg Clin N Am
3 Neurosurgery
2 PLoS One
2 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Br J Cancer

  1. WANG S, O'Rourke DM, Chawla S, Verma G, et al
    Multiparametric magnetic resonance imaging in the assessment of anti-EGFRvIII chimeric antigen receptor T cell therapy in patients with recurrent glioblastoma.
    Br J Cancer. 2018 Nov 27. pii: 10.1038/s41416-018-0342.
    PubMed     Text format     Abstract available


    Cancer

  2. PRINTZ C
    Can a repurposed vaccine fight cancer?: Use of the poliovirus vaccine to target brain tumors draws interest.
    Cancer. 2018;124:4273-4274.
    PubMed     Text format    


    Cancer Res

  3. MORGAN MA, Canman CE
    Replication Stress: An Achilles' Heel of Glioma Cancer Stem-like Cells.
    Cancer Res. 2018 Nov 29. pii: 0008-5472.CAN-18-2439.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  4. ROBBINS DJ, Rodriguez-Blanco J, Li B, Shen C, et al
    A CK1alpha activator penetrates the brain, and shows efficacy against drug-resistant metastatic medulloblastoma.
    Clin Cancer Res. 2018 Nov 28. pii: 1078-0432.CCR-18-1319.
    PubMed     Text format     Abstract available

  5. THULBORN KR, Lu A, Atkinson IC, Pauliah M, et al
    Residual Tumor Volume, Cell Volume Fraction and Tumor Cell Kill During Fractionated Chemoradiation Therapy of Human Glioblastoma using Quantitative Sodium MR imaging.
    Clin Cancer Res. 2018 Nov 28. pii: 1078-0432.CCR-18-2079.
    PubMed     Text format     Abstract available

  6. DAVIDSON TB, Lee AH, Hsu M, Sedighim S, et al
    Expression of PD-1 by T cells in malignant glioma patients reflects exhaustion and activation.
    Clin Cancer Res. 2018 Nov 29. pii: 1078-0432.CCR-18-1176.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  7. LIEBERMAN FS, Wang M, Robins HI, Tsien CI, et al
    Phase 2 Study of Radiation Therapy Plus Low Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420.
    Int J Radiat Oncol Biol Phys. 2018 Nov 26. pii: S0360-3016(18)33955.
    PubMed     Text format     Abstract available


    J Neurooncol

  8. LAMBA N, Fick T, Nandoe Tewarie R, Broekman ML, et al
    Management of hydrocephalus in patients with leptomeningeal metastases: an ethical approach to decision-making.
    J Neurooncol. 2018;140:5-13.
    PubMed     Text format     Abstract available

  9. GOEBEL S, Mehdorn HM
    A missing piece? Neuropsychiatric functioning in untreated patients with tumors within the cerebellopontine angle.
    J Neurooncol. 2018;140:145-153.
    PubMed     Text format     Abstract available

  10. MAKINO K, Nakamura H, Shinojima N, Kuroda JI, et al
    BCL2 expression is associated with a poor prognosis independent of cellular origin in primary central nervous system diffuse large B-cell lymphoma.
    J Neurooncol. 2018;140:115-121.
    PubMed     Text format     Abstract available

  11. SHEN CC, You WC, Sun MH, Lee SD, et al
    Outcome of partially irradiated recurrent nonfunctioning pituitary macroadenoma by gamma knife radiosurgery.
    J Neurooncol. 2018;139:767-775.
    PubMed     Text format     Abstract available

  12. STEVENS SP, Main C, Bailey S, Pizer B, et al
    The utility of routine surveillance screening with magnetic resonance imaging (MRI) to detect tumour recurrence in children with low-grade central nervous system (CNS) tumours: a systematic review.
    J Neurooncol. 2018;139:507-522.
    PubMed     Text format     Abstract available

  13. PUATAWEEPONG P, Dhanachai M, Hansasuta A, Dangprasert S, et al
    Clinical outcomes of perioptic tumors treated with hypofractionated stereotactic radiotherapy using CyberKnife(R) stereotactic radiosurgery.
    J Neurooncol. 2018;139:679-688.
    PubMed     Text format     Abstract available

  14. REBLIN M, Ketcher D, Forsyth P, Mendivil E, et al
    Outcomes of an electronic social network intervention with neuro-oncology patient family caregivers.
    J Neurooncol. 2018;139:643-649.
    PubMed     Text format     Abstract available

  15. LIN FH, Zhang XH, Zhang J, He ZQ, et al
    Fluorescein sodium-guided biopsy or resection in primary central nervous system lymphomas with contrast-enhancing lesion in MRI.
    J Neurooncol. 2018;139:757-765.
    PubMed     Text format     Abstract available

  16. HEITZER AM, Ashford JM, Hastings C, Liu APY, et al
    Neuropsychological outcomes of patients with low-grade glioma diagnosed during the first year of life.
    J Neurooncol. 2018 Nov 22. pii: 10.1007/s11060-018-03048.
    PubMed     Text format     Abstract available

  17. MORSHED RA, Han SJ, Hervey-Jumper SL, Pekmezci M, et al
    Molecular features and clinical outcomes in surgically treated low-grade diffuse gliomas in patients over the age of 60.
    J Neurooncol. 2018 Nov 29. pii: 10.1007/s11060-018-03044.
    PubMed     Text format     Abstract available

  18. DWORKIN M, Mehan W, Niemierko A, Kamran SC, et al
    Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide.
    J Neurooncol. 2018 Nov 28. pii: 10.1007/s11060-018-03063.
    PubMed     Text format     Abstract available

  19. COBURGER J, Wirtz CR
    Fluorescence guided surgery by 5-ALA and intraoperative MRI in high grade glioma: a systematic review.
    J Neurooncol. 2018 Nov 28. pii: 10.1007/s11060-018-03052.
    PubMed     Text format     Abstract available

  20. TSOLI M, Shen H, Mayoh C, Franshaw L, et al
    Correction to: International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma.
    J Neurooncol. 2018 Nov 27. pii: 10.1007/s11060-018-03060.
    PubMed     Text format     Abstract available

  21. KNUDSEN-BAAS KM, Johannesen TB, Myklebust TA, Aarseth JH, et al
    Antiepileptic and psychiatric medication in a nationwide cohort of patients with glioma WHO grade II-IV.
    J Neurooncol. 2018;140:739-748.
    PubMed     Text format     Abstract available

  22. DELEV D, Heiland DH, Franco P, Reinacher P, et al
    Surgical management of lower-grade glioma in the spotlight of the 2016 WHO classification system.
    J Neurooncol. 2018 Nov 22. pii: 10.1007/s11060-018-03030.
    PubMed     Text format     Abstract available

  23. HEITZER AM, Ashford JM, Harel BT, Schembri A, et al
    Computerized assessment of cognitive impairment among children undergoing radiation therapy for medulloblastoma.
    J Neurooncol. 2018 Nov 22. pii: 10.1007/s11060-018-03046.
    PubMed     Text format     Abstract available


    J Neurosurg


  24. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
    J Neurosurg. 2018 Oct 1:1-11. doi: 10.3171/2018.4.JNS172909.
    PubMed     Text format     Abstract available


  25. A modern series of subdiaphragmatic craniopharyngiomas.
    J Neurosurg. 2018 Oct 1:1-6. doi: 10.3171/2018.4.JNS172330.
    PubMed     Text format     Abstract available


  26. Ventricle contact is associated with lower survival and increased peritumoral perfusion in glioblastoma.
    J Neurosurg. 2018 Oct 1:1-7. doi: 10.3171/2018.5.JNS18340.
    PubMed     Text format     Abstract available


  27. Transcortical insular glioma resection: clinical outcome and predictors.
    J Neurosurg. 2018 Oct 1:1-11. doi: 10.3171/2018.4.JNS18424.
    PubMed     Text format     Abstract available


  28. Erratum. Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
    J Neurosurg. 2018 Sep 1:1. doi: 10.3171/2018.8.JNS161170.
    PubMed     Text format    


  29. Erratum. A prospective randomized trial of the optimal dose of mannitol for intraoperative brain relaxation in patients undergoing craniotomy for supratentorial brain tumor resection.
    J Neurosurg. 2018;129:551-552.
    PubMed     Text format    


  30. Endonasal endoscopic transsphenoidal resection of intrinsic third ventricular craniopharyngioma: surgical results.
    J Neurosurg. 2018 Nov 1:1-11. doi: 10.3171/2018.5.JNS18198.
    PubMed     Text format     Abstract available


  31. Preserve or sacrifice the stalk? Endocrinological outcomes, extent of resection, and recurrence rates following endoscopic endonasal resection of craniopharyngiomas.
    J Neurosurg. 2018 Nov 1:1-9. doi: 10.3171/2018.6.JNS18901.
    PubMed     Text format     Abstract available


  32. Harvey Cushing's craniopharyngioma treatment: Part 2. Surgical strategies and results of his pioneering series.
    J Neurosurg. 2018 Oct 1:1-15. doi: 10.3171/2018.5.JNS18154.
    PubMed     Text format     Abstract available


  33. Harvey Cushing's craniopharyngioma treatment: Part 1. Identification and clinicopathological characterization of this challenging pituitary tumor.
    J Neurosurg. 2018 Oct 1:1-15. doi: 10.3171/2018.5.JNS18153.
    PubMed     Text format     Abstract available


    Neuro Oncol

  34. BALE TA, Jordan JT, Rapalino O, Ramamurthy N, et al
    Financially Effective Test-Algorithm to Identify an Aggressive, EGFR-amplified Variant of IDH-Wildtype, Lower-Grade Diffuse Glioma.
    Neuro Oncol. 2018 Nov 28. pii: 5212363. doi: 10.1093.
    PubMed     Text format     Abstract available

  35. LUDMIR EB, Mandel JJ, McAleer MF, de Groot JF, et al
    Disparities along the glioblastoma clinical trials landscape.
    Neuro Oncol. 2018 Nov 26. pii: 5209731. doi: 10.1093.
    PubMed     Text format    

  36. PRABHU AH, Kant S, Kesarwani P, Ahmed K, et al
    Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastoma.
    Neuro Oncol. 2018 Nov 10. pii: 5172259. doi: 10.1093.
    PubMed     Text format     Abstract available

  37. DI STEFANO AL, Savatovsky J, Feuvret L, Villa C, et al
    CNS inflammatory disorder after concurrent radiotherapy-temozolomide and nivolumab in a glioblastoma patient.
    Neuro Oncol. 2018 Nov 23. pii: 5203543. doi: 10.1093.
    PubMed     Text format    


    Neurology


  38. Clinical Reasoning: Transient speech deficits in a patient with history of medulloblastoma.
    Neurology. 2018;91:1031.
    PubMed     Text format    


    Neurosurg Clin N Am

  39. DONOVAN LE, Lassman AB
    Chemotherapy Treatment and Trials in Low-Grade Gliomas.
    Neurosurg Clin N Am. 2019;30:103-109.
    PubMed     Text format     Abstract available

  40. WANG TJC, Mehta MP
    Low-Grade Glioma Radiotherapy Treatment and Trials.
    Neurosurg Clin N Am. 2019;30:111-118.
    PubMed     Text format     Abstract available

  41. DUFFAU H
    Higher-Order Surgical Questions for Diffuse Low-Grade Gliomas: Supramaximal Resection, Neuroplasticity, and Screening.
    Neurosurg Clin N Am. 2019;30:119-128.
    PubMed     Text format     Abstract available

  42. SANAI N
    How to Build a Neurosurgical Oncology Practice Specializing in Gliomas.
    Neurosurg Clin N Am. 2019;30:129-136.
    PubMed     Text format     Abstract available

  43. PALLUD J, McKhann GM
    Diffuse Low-Grade Glioma-Related Epilepsy.
    Neurosurg Clin N Am. 2019;30:43-54.
    PubMed     Text format     Abstract available

  44. SMITS A, Jakola AS
    Clinical Presentation, Natural History, and Prognosis of Diffuse Low-Grade Gliomas.
    Neurosurg Clin N Am. 2019;30:35-42.
    PubMed     Text format     Abstract available

  45. MCKHANN GM, Duffau H
    Low-Grade Glioma: Epidemiology, Pathophysiology, Clinical Features, and Treatment.
    Neurosurg Clin N Am. 2019;30:xiii-xiv.
    PubMed     Text format    

  46. ROSSI M, Sani S, Nibali MC, Fornia L, et al
    Mapping in Low-Grade Glioma Surgery: Low- and High-Frequency Stimulation.
    Neurosurg Clin N Am. 2019;30:55-63.
    PubMed     Text format     Abstract available

  47. TORRES D, Canoll P
    Alterations in the Brain Microenvironment in Diffusely Infiltrating Low-Grade Glioma.
    Neurosurg Clin N Am. 2019;30:27-34.
    PubMed     Text format     Abstract available

  48. BREADY D, Placantonakis DG
    Molecular Pathogenesis of Low-Grade Glioma.
    Neurosurg Clin N Am. 2019;30:17-25.
    PubMed     Text format     Abstract available


    Neurosurgery

  49. MOHAMMADI AM, Sharma M, Beaumont TL, Juarez KO, et al
    Upfront Magnetic Resonance Imaging-Guided Stereotactic Laser-Ablation in Newly Diagnosed Glioblastoma: A Multicenter Review of Survival Outcomes Compared to a Matched Cohort of Biopsy-Only Patients.
    Neurosurgery. 2018 Nov 23. pii: 5200832. doi: 10.1093.
    PubMed     Text format     Abstract available

  50. FUJIO S, Juratli TA, Arita K, Hirano H, et al
    A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas.
    Neurosurgery. 2018 Nov 27. pii: 5210774. doi: 10.1093.
    PubMed     Text format     Abstract available

  51. VALDES PA, Golby AJ
    Commentary: Extent of Resection and Residual Tumor Thresholds for Postoperative Total Seizure Freedom in Epileptic Adult Patients Harboring a Supratentorial Diffuse Low-Grade Glioma.
    Neurosurgery. 2018 Nov 26. pii: 5209702. doi: 10.1093.
    PubMed     Text format    


    PLoS One

  52. LEITNER J, Pelster S, Schopf V, Berghoff AS, et al
    High correlation of temporal muscle thickness with lumbar skeletal muscle cross-sectional area in patients with brain metastases.
    PLoS One. 2018;13:e0207849.
    PubMed     Text format     Abstract available

  53. VAIDYA M, Bacchus M, Sugaya K
    Differential sequences of exosomal NANOG DNA as a potential diagnostic cancer marker.
    PLoS One. 2018;13:e0197782.
    PubMed     Text format     Abstract available


    Radiology

  54. BARBORIAK DP, Zhang Z, Desai P, Snyder BS, et al
    Interreader Variability of Dynamic Contrast-enhanced MRI of Recurrent Glioblastoma: The Multicenter ACRIN 6677/RTOG 0625 Study.
    Radiology. 2018 Nov 27:181296. doi: 10.1148/radiol.2019181296.
    PubMed     Text format     Abstract available

  55. WOLF RL
    MRI of Recurrent Glioblastoma: Reliability and Reality.
    Radiology. 2018 Nov 27:182530. doi: 10.1148/radiol.2018182530.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: